Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 4Thoracic 1Head & Neck 1Gastrointestinal 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Patient Navigation × Tumor-Agnostic × Clear all
NCT04234646 2026-06-02

Patient Navigation 2.0

Northwestern University

Phase NA Completed
600 enrolled
Tumor-Agnostic

Neoplasms

NCT03176576 2021-09-14

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
28 enrolled
Tumor-Agnostic

Neoplasms

NCT03226405 2020-04-21

Patient Navigation to Improve Patient-Centered Cancer Care

Massachusetts General Hospital

Phase NA Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

NCT03305965 2017-10-10

The Effectiveness of Patient Navigation in Cancer Care

The Netherlands Cancer Institute

Phase NA Unknown
120 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡